Epidemiological, clinical, diagnostic, and therapeutic features of histoplasmosis: A systematic review

• Published in: Journal de mycologie médicale Vol. 34; no. 2; p. 101474
• Main Authors: Zida, Adama, Guiguemdé, Thierry K, Sawadogo, Marcel P, Tchekounou, Chanolle, Sangaré, Ibrahim, Bamba, Sanata
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01-06-2024
• Subjects: Africa - epidemiology; Amphotericin B - therapeutic use; Antifungal Agents - therapeutic use; Clinical forms; Epidemiology; Histoplasma - isolation & purification; Histoplasma capsulatum var capsulatum; Histoplasma capsulatum var duboisii; Histoplasmosis; Histoplasmosis - diagnosis; Histoplasmosis - drug therapy; Histoplasmosis - epidemiology; Humans; Itraconazole - therapeutic use; Treatment; Africa; Clinical forms; Histoplasmosis; Treatment; Epidemiology; Histoplasma capsulatum var capsulatum; Histoplasma capsulatum var duboisii
• ISSN: 1156-5233; 1773-0449; 1773-0449
• DOI: 10.1016/j.mycmed.2024.101474

Histoplasmosis is a mycosis due to a dimorphic fungus Histoplasma capsulatum. This study aimed at providing an overview of histoplasmosis epidemiological, clinical, diagnostic, and therapeutic aspects from the last 30 years.
This review was carried out using a systematic literature search on histoplasmosis from 1992 to 2021. We describe the clinical features, diagnostic methods and treatment. Empirical searches were conducted via the databases PubMed, Google Scholar and Science Direct.
Between 1992 and 2021, 190 manuscripts were published and reported 212 cases of histoplasmosis. These publications included 115 and 97 cases of American and African histoplasmosis respectively. The number of publications increased over the last ten years with a maximum in 2020 (12.34 % of the cases reported). The disseminated forms of histoplasmosis were the most frequently reported cases as compared to the localized forms. This was the case with the American histoplasmosis (75.65 %) as well as with the African histoplasmosis (55.67 %). Itraconazole (31.17 %) and Amphotericin B (26.62 %) were the most used drugs in the management of these cases.
American histoplasmosis is distributed worldwide whereas African histoplasmosis is mainly present in intertropical Africa. There is a critical need for setting up a global surveillance system, towards a better understanding of the disease.